Hypertension Management in Pregnancy

Literature Cited

1. 1.

   Ford ND, Cox S, Ko JY, et al. 2022.. Hypertensive disorders in pregnancy and mortality at delivery hospitalization—United States, 2017–2019. . Morb. Mortal. Wkly. Rep. 71::585–91
   [Google Scholar]
2. 2.

   Joseph KS, Boutin A, Lisonkova S, et al. 2021.. Maternal mortality in the United States: recent trends, current status, and future considerations. . Obstet. Gynecol. 137::763–71
   [Google Scholar]
3. 3.

   van Oppen AC, van der Tweel I, Alsbach GP, et al. 1996.. A longitudinal study of maternal hemodynamics during normal pregnancy. . Obstet. Gynecol. 88::40–46
   [Google Scholar]
4. 4.

   Mahendru AA, Everett TR, Wilkinson IB, et al. 2014.. A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. . J. Hypertens. 32::849–56
   [Google Scholar]
5. 5.

   Halpern DG, Weinberg CR, Pinnelas R, et al. 2019.. Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. . J. Am. Coll. Cardiol. 73::457–76
   [Google Scholar]
6. 6.

   Nanna M, Stergiopoulos K. 2014.. Pregnancy complicated by valvular heart disease: an update. . J. Am. Heart Assoc. 3::e000712
   [Google Scholar]
7. 7.

   Liu LX, Arany Z. 2014.. Maternal cardiac metabolism in pregnancy. . Cardiovasc. Res. 101::545–53
   [Google Scholar]
8. 8.

   Robson SC, Dunlop W, Boys RJ, Hunter S. 1987.. Cardiac output during labour. . BMJ (Clin. Res. Ed.) 295::1169–72
   [Google Scholar]
9. 9.

   ACOG (Am. Coll. Obstet. Gynecol.). 2020.. Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222. . Obstet. Gynecol. 135::e237–60
   [Google Scholar]
10. 10.

    Garovic VD, Dechend R, Easterling T, et al. 2022.. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. . Hypertension 79::e21–41
    [Google Scholar]
11. 11.

    Lindheimer MD, August P. 2009.. Aldosterone, maternal volume status and healthy pregnancies: a cycle of differing views. . Nephrol. Dial. Transplant. 24::1712–14
    [Google Scholar]
12. 12.

    Lyall F, Robson SC, Bulmer JN. 2013.. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. . Hypertension 62::1046–54
    [Google Scholar]
13. 13.

    Rana S, Lemoine E, Granger JP, Karumanchi SA. 2019.. Preeclampsia: pathophysiology, challenges, and perspectives. . Circ. Res. 124::1094–112
    [Google Scholar]
14. 14.

    Davenport MH, Ruchat SM, Poitras VJ, et al. 2018.. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis. . Br. J. Sports Med. 52::1367–75
    [Google Scholar]
15. 15.

    Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. 2007.. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. . Lancet 369::1791–98
    [Google Scholar]
16. 16.

    Duley L, Meher S, Hunter KE, et al. 2019.. Antiplatelet agents for preventing pre-eclampsia and its complications. . Cochrane Database Syst. Rev. 2019::CD004659
    [Google Scholar]
17. 17.

    LeFevre ML. 2014.. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. . Ann. Intern. Med. 161::819–26
    [Google Scholar]
18. 18.

    ACOG (Am. Coll. Obstet. Gynecol.). 2018.. Low-dose aspirin use during pregnancy. ACOG Committee Opinion No. 743. . Obstet. Gynecol. 132::e44–52
    [Google Scholar]
19. 19.

    Wu P, Haththotuwa R, Kwok CS, et al. 2017.. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. . Circ. Cardiovasc. Qual. Outcomes 10::e003497
    [Google Scholar]
20. 20.

    Lo CCW, Lo ACQ, Leow SH, et al. 2020.. Future cardiovascular disease risk for women with gestational hypertension: a systematic review and meta-analysis. . J. Am. Heart Assoc. 9::e013991
    [Google Scholar]
21. 21.

    Whelton PK, Carey RM, Aronow WS, et al. 2018.. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. . Hypertension 71::1269–324
    [Google Scholar]
22. 22.

    Cifu AS, Davis AM. 2017.. Prevention, detection, evaluation, and management of high blood pressure in adults. . JAMA 318::2132–34
    [Google Scholar]
23. 23.

    Hauspurg A, Sutton EF, Catov JM, Caritis SN. 2018.. Aspirin effect on adverse pregnancy outcomes associated with stage 1 hypertension in a high-risk cohort. . Hypertension 72::202–7
    [Google Scholar]
24. 24.

    ACOG (Am. Coll. Obstet. Gynecol.). 2019.. Chronic hypertension in pregnancy. ACOG Practice Bulletin No. 203. . Obstet. Gynecol. 133::e26–50
    [Google Scholar]
25. 25.

    Berks D, Steegers EAP, Molas M, Visser W. 2009.. Resolution of hypertension and proteinuria after preeclampsia. . Obstet. Gynecol. 114::1307–14
    [Google Scholar]
26. 26.

    Dominguez JE, Habib AS, Krystal AD. 2018.. A review of the associations between obstructive sleep apnea and hypertensive disorders of pregnancy and possible mechanisms of disease. . Sleep Med. Rev. 42::37–46
    [Google Scholar]
27. 27.

    Meah VL, Cockcroft JR, Backx K, et al. 2016.. Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses. . Heart 102::518–26
    [Google Scholar]
28. 28.

    Abalos E, Duley L, Steyn DW, Gialdini C. 2018.. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. . Cochrane Database Syst. Rev. 10::CD002252
    [Google Scholar]
29. 29.

    Magee LA, von Dadelszen P, Singer J, et al. 2016.. The CHIPS randomized controlled trial (Control of Hypertension in Pregnancy Study): Is severe hypertension just an elevated blood pressure?. Hypertension 68::1153–59
    [Google Scholar]
30. 30.

    Tita AT, Szychowski JM, Boggess K, et al. 2022.. Treatment for mild chronic hypertension during pregnancy. . N. Engl. J. Med. 386::1781–92
    [Google Scholar]
31. 31.

    Sibai BM, Lindheimer M, Hauth J, et al. 1998.. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. . N. Engl. J. Med. 339::667–71
    [Google Scholar]
32. 32.

    Sibai BM. 2002.. Chronic hypertension in pregnancy. . Obstet. Gynecol. 100::369–77
    [Google Scholar]
33. 33.

    Ferrer RL, Sibai BM, Mulrow CD, et al. 2000.. Management of mild chronic hypertension during pregnancy: a review. . Obstet. Gynecol. 96::849–60
    [Google Scholar]
34. 34.

    Sibai BM, Mercer BM, Schiff E, Friedman SA. 1994.. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: a randomized controlled trial. . Am. J. Obstet. Gynecol. 171::818–22
    [Google Scholar]
35. 35.

    Petersen EE, Davis NL, Goodman D, et al. 2019.. Vital signs: pregnancy-related deaths, United States, 2011–2015, and strategies for prevention, 13 states, 2013–2017. . Morb. Mortal. Wkly. Rep. 68::423–29
    [Google Scholar]
36. 36.

    Mostello D, Kallogjeri D, Tungsiripat R, Leet T. 2008.. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. . Am. J. Obstet. Gynecol. 199::55.e1–7
    [Google Scholar]
37. 37.

    Roberts JM, Pearson G, Cutler J, Lindheimer M. 2003.. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. . Hypertension 41::437–45
    [Google Scholar]
38. 38.

    Mito A, Murashima A, Wada Y, et al. 2019.. Safety of amlodipine in early pregnancy. . J. Am. Heart Assoc. 8::e012093
    [Google Scholar]
39. 39.

    Ratnapalan S, Koren G. 2002.. Taking ACE inhibitors during pregnancy. Is it safe?. Can. Fam. Phys. 48::1047–49
    [Google Scholar]
40. 40.

    Easterling TR, Carr DB, Brateng D, et al. 2001.. Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. . Obstet. Gynecol. 98::427–33
    [Google Scholar]
41. 41.

    Steele DW, Adam GP, Saldanha IJ, et al. 2023.. Management of postpartum hypertensive disorders of pregnancy. Rep., Agency Healthcar. Res. Qual., Rockville, MD:. https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy.pdf
    [Google Scholar]
42. 42.

    Ascarelli MH, Johnson V, McCreary H, et al. 2005.. Postpartum preeclampsia management with furosemide: a randomized clinical trial. . Obstet. Gynecol. 105::29–33
    [Google Scholar]
43. 43.

    Lopes Perdigao J, Lewey J, Hirshberg A, et al. 2021.. Furosemide for accelerated recovery of blood pressure postpartum in women with a hypertensive disorder of pregnancy: a randomized controlled trial. . Hypertension 77::1517–24
    [Google Scholar]
44. 44.

    Cagino K, Prabhu M, Sibai B. 2023.. Is magnesium sulfate therapy warranted in all cases of late postpartum severe hypertension? A suggested approach to a clinical conundrum. . Am. J. Obstet. Gynecol. 229::641–46
    [Google Scholar]
45. 45.

    Bramham K, Parnell B, Nelson-Piercy C, et al. 2014.. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. . BMJ 348::g2301
    [Google Scholar]
46. 46.

    Panaitescu AM, Syngelaki A, Prodan N, et al. 2017.. Chronic hypertension and adverse pregnancy outcome: a cohort study. . Ultrasound Obstet. Gynecol. 50::228–35
    [Google Scholar]
47. 47.

    Ramakrishnan A, Lee LJ, Mitchell LE, Agopian AJ. 2015.. Maternal hypertension during pregnancy and the risk of congenital heart defects in offspring: a systematic review and meta-analysis. . Pediatr. Cardiol. 36:(7):1442–51
    [Google Scholar]
48. 48.

    Barry MJ, Nicholson WK, Silverstein M, et al. 2023.. Screening for hypertensive disorders of pregnancy: US Preventive Services Task Force final recommendation statement. . JAMA 330::1074–82
    [Google Scholar]
49. 49.

    Grobman WA, Parker CB, Willinger M, et al. 2018.. Racial disparities in adverse pregnancy outcomes and psychosocial stress. . Obstet. Gynecol. 131::328–35
    [Google Scholar]
50. 50.

    MacDorman MF, Thoma M, Declcerq E, Howell EA. 2021.. Racial and ethnic disparities in maternal mortality in the United States using enhanced vital records, 2016–2017. . Am. J. Public Health 111::1673–81
    [Google Scholar]
51. 51.

    Lopes Perdigao J, Hirshberg A, Koelper N, et al. 2020.. Postpartum blood pressure trends are impacted by race and BMI. . Pregnancy Hypertens. 20::14–18
    [Google Scholar]